NRC Health (NRC)

NRC Health Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	9.04	11.6	24.78	30.97	31.8	37.47
Depreciation & Amortization	8.25	7.62	6.02	5.9	5.28	6.37
Stock-Based Compensation	4.75	3.31	0.28	0.94	1.2	0.62
Other Adjustments	0.82	3	-0.28	-0.68	1.34	0.04
Change in Receivables	0.49	-0.05	1.76	2.08	-0.73	0.34
Changes in Accounts Payable	0.49	0.17	-0.11	0.18	-0.59	0
Changes in Accrued Expenses	1.25	1.67	0.17	-0.81	-2.95	-0.29
Changes in Income Taxes Payable	1.15	-0.19	0.16	0.8	0.01	0.48
Changes in Unearned Revenue	1.49	0.27	0.22	-0.36	-2.01	1.39
Changes in Other Operating Activities	-0.81	-0.95	1.62	-0.91	2.93	-0.09
Operating Cash Flow	26.98	26.45	34.63	38.11	36.27	46.34
Operating Cash Flow Growth	-7.70%	-23.61%	-9.15%	5.10%	-21.75%	14.05%
Capital Expenditures	-9.55	-10.71	-15.45	-15.78	-9.84	-5.51
Sale of Property, Plant & Equipment	-	-	-	0	-	-
Payments for Business Acquisitions	-	-	-4.83	-	-	-3
Investing Cash Flow	-9.55	-10.71	-20.28	-15.78	-9.84	-8.51
Short-Term Debt Issued	31.5	37	49.5	15	-	-
Short-Term Debt Repaid	-35	-37	-49.5	-15	-	-
Net Short-Term Debt Issued (Repaid)	-3.5	-0	0	0	-	-
Long-Term Debt Issued	19.94	47.68	32	19	-	-
Long-Term Debt Repaid	-3.73	-31.42	-5.99	-4.53	-4.31	-4.09
Net Long-Term Debt Issued (Repaid)	16.21	16.26	26.01	14.47	-4.31	-4.09
Issuance of Common Stock	0.14	0.13	-	0.58	-	0.45
Repurchase of Common Stock	-17.6	-20.59	-31.26	-19.1	-27.81	-4.86
Net Common Stock Issued (Repurchased)	-17.46	-20.46	-31.26	-18.52	-27.81	-4.42
Common Dividends Paid	-11.83	-10.98	-11.45	-36.37	-20.96	-9.16
Other Financing Activities	-0.8	-0.66	-0.06	-0.3	-2.51	-0.49
Financing Cash Flow	-17.39	-15.84	-16.76	-40.71	-55.58	-18.16
Effect of Exchange Rate Changes on Cash and Cash Equivalents	-	-	-	-0	-0.18	0
Net Cash Flow	0.05	-0.09	-2.42	-18.37	-29.34	19.67
Free Cash Flow	17.43	15.74	19.18	22.33	26.43	40.83
Free Cash Flow Growth	10.71%	-17.90%	-14.13%	-15.50%	-35.27%	11.40%
FCF Margin	12.57%	11.46%	13.40%	15.03%	17.44%	27.60%
Free Cash Flow Per Share	0.79	0.70	0.81	0.91	1.06	1.59
Levered Free Cash Flow	24.02	25.74	43.43	34.47	20.32	35.73
Unlevered Free Cash Flow	14.46	12.57	19.31	20.06	27.39	41.09

Updated May 6, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q